Relationship of laboratory results with clinical signs and symptoms of patients with vulvovaginal candidiasis and the significance of the sexual partners for the maintenance of the infection;Correlação entre os resultados laboratoriais e os sinais e sintomas clínicos das pacientes com candidíase vulvovaginal e relevância dos parceiros sexuais na manutenção da infecção em São Paulo, Brasil

Revista Brasileira de Ginecologia e Obstetricia

Volumn 29, Issue 2, 2007, Pages 80-84

  Boatto, Humberto Fabio ^a   De Moraes, Maria Sayonara ^a   Machado, Alexandre Paulo ^b   Girão, Manoel João Batista Castelo ^c   Fischman, Olga ^c  

^a Unidade Básica de Saúde CS II de Jardim Castelo de Ferraz de Vasconcelos   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Candida albicans; Candidiasis, vulvovaginal; Laboratory techniques and procedures; Sexual partners; Signs and symptoms

Indexed keywords

EID: 34248182857     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Geva A, Bornstein J, Dan M, Shoham HK, Sobel JD. The VI-SENSE-vaginal discharge self-test to facilitate management of vaginal symptoms. Am J Obstet Gynecol. 2006; 195(5):1351-6.
2. Schaller M. [Candida albicans - interactions with the mucosa and the immune system]. J Dtsch Dermatol Ges. 2006; 4(4):328-36; quiz 337-8. German.
3. Mendling W, Seebacher C, Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics; German Speaking Mycological Society; German Dermatological Society. Guideline vulvovaginal candidosis: guideline of the German Dermatological Society, the German Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics. Mycoses. 2003; 46(9-10):365-9.
4. Barrenetxea Ziarrusta G. Vulvovaginitis candidiásica. Rev Iberoam Micol. 2002; 19(1):22-4.
5. Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int J Gynaecol Obstet. 2000; 71 Suppl 1:S21-7.
6. Odds FC, Webster CE, Mayuranathan P, Simmons PD. Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis. J Med Vet Mycol. 1988; 26(5):277-83.
7. Lopes Consolaro ME, Aline Albertoni T, Shizue Yoshida C, Mazucheli J, Peralta RM, Estivalet Svidzinski TI. Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringa, Parana, Brazil. Rev Iberoam Micol. 2004; 21(4):202-5.
8. Rosa MI, Rumel D. Fatores associados à candidíase vulvovaginal: estudo exploratório. Rev Bras Ginecol Obstet. 2004; 26(1):65-70.
9. Spinillo A, Capuzzo E, Gulminetti R, Marone P, Colonna L, Piazzi G. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol. 1997; 176(1 Pt 1):138-41.
10. Ribeiro MA, Dietze R, Paula CR, Da Matta DA, Colombo AL. Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia. 2001; 151(1):5-10.
11. Crocco EI, Mimica LMJ, Muramatu LH, Garcia C, Souza VM, Ruiz LRB, et al. Identificação de espécies de Candida e susceptibilidade antifúngica in vitro: estudo de 100 pacientes com candidíases superficiais. An Bras Dermatol. 2004; 79(6):689-97.
12. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005; 43(5):2155-62.
13. Azzam-W M, Cermeno-Vivas JR, Orellan-Garcia Y, Penna SJ. Vulvovaginitis caused by Candida spp. and Trichomonas vaginalis in sexually active women. Invest Clin. 2002; 43(1):3-13.
14. Galle LC, Gianinni MJSM. Prevalência e susceptibilidade de leveduras vaginais. J Bras Patol Med Lab. 2004; 40(4):229-36.
15. Willinger B, Manafi M. Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species. Mycoses. 1999; 42(1-2):61-5.
16. Novikova N, Rodrigues A, Mardh PA. Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar? Infect Dis Obstet Gynecol. 2002; 10(2):89-92.
17. Gultekin B, Yazici V, Aydin N. Distribution of Candida species in vaginal specimens and evaluation of CHROMagar Candida medium. Mikrobiyol Bul. 2005; 39(3):319-24.
18. Ringdahl EN. Treatment of recurrent vulvovaginal candidiasis. Am Fam Physician. 2000; 61(11):3306-12, 3317.
19. Fidel PL Jr, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev. 1996; 9(3):335-48.
20. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis. 1992; 14 Suppl 1:S148-53.
21. Moreira D, Paula CR. Vulvovaginal candidiasis. Int J Gynaecol Obstet. 2006; 92(3):266-7.
22. Omar AA. Gram stain versus culture in the diagnosis of vulvovaginal candidiasis. East Mediterr Health J. 2001; 7(6):925-34.
23. Acikgoz ZC, Sancak B, Gamberzade S, Misirlioglu M. Prevalence of Candida dubliniensis among the stored vaginal Candida isolates in a Turkish hospital. Mycoses. 2004; 47(9-10):393-6.